Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dialysis01:27

Dialysis

269
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

605
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
605

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

K-SALT Equation for Urinary Sodium Estimation in CKD.

Kidney international reports·2026
Same author

Advances and unmet needs in the management of proliferative lupus nephritis: evidence, guidelines, and emerging therapies.

Kidney research and clinical practice·2026
Same author

Health-Related Quality of Life in Chronic Cough: A Comparative Analysis With Other Chronic Diseases.

Allergy, asthma & immunology research·2026
Same author

Design and Baseline Characteristics of the Korean Age-Related Maculopathy Study (KARMS): A Nationwide Multicenter Prospective Observational Study.

Ophthalmology science·2026
Same author

Automated detection and segmentation of Weiss ring in fundus photography images using deep learning.

Scientific reports·2026
Same author

Systemic Proteome Profiling to Differentiate Primary Glomerular Diseases.

Journal of the American Society of Nephrology : JASN·2026

Related Experiment Video

Updated: Jun 8, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

719

Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis.

Chaewon Kang1, Jinyoung Han1,2, Seongmin Son3

  • 1Department of Applied Artificial Intelligence, Sungkyunkwan University, Seoul, Republic of Korea.

Scientific Reports
|November 5, 2024
PubMed
Summary

This study introduces a novel AI model for managing anemia in end-stage kidney disease (ESKD) patients. The model optimizes erythropoiesis-stimulating agent (ESA) dosing and predicts transfusion needs, improving patient care.

Keywords:
AnemiaArtificial intelligenceEnd-stage kidney diseaseErythropoiesis-stimulating agentsTransfusion alert

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Related Experiment Videos

Last Updated: Jun 8, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

719
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Area of Science:

  • Nephrology
  • Artificial Intelligence
  • Biomedical Informatics

Background:

  • Anemia is a common complication in end-stage kidney disease (ESKD), requiring careful management with erythropoiesis-stimulating agents (ESAs).
  • Maintaining target hemoglobin (Hb) levels and anticipating red blood cell transfusion needs in ESKD patients on dialysis presents significant clinical challenges.

Purpose of the Study:

  • To develop and validate an advanced artificial intelligence model for efficient anemia management in hemodialysis patients.
  • To propose a novel alert system for predicting the necessity of red blood cell (RBC) transfusions in ESKD patients.

Main Methods:

  • Retrospective data collection from 252 hemodialysis patients (2017-2022) including demographics, dialysis metrics, drug administration, lab tests, and transfusion history.
  • Development of a gated recurrent unit-attention-based module (GAM) for Hb level prediction and ESA dose recommendation.
  • Implementation of a transfusion alert framework integrated with the GAM model.

Main Results:

  • The GAM model demonstrated superior Hb level prediction accuracy (R-squared = 0.60) compared to traditional machine learning algorithms.
  • ESA dose recommendations from the GAM model showed high concordance with clinical expert assessments (accuracy = 0.78).
  • The model achieved exceptional accuracy (0.99) in generating transfusion alerts.

Conclusions:

  • The GAM model offers a promising approach to enhance anemia management in ESKD patients undergoing chronic dialysis.
  • Optimized ESA dosing and timely transfusion alerts facilitated by the GAM model can lead to improved patient outcomes.
  • This AI-driven system has the potential to support clinical decision-making in managing anemia in ESKD.